共 50 条
- [1] TREATMENT OF HTLV-III/LAV-INFECTED PATIENTS WITH D-PENICILLAMINE [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-2 (10): : 1531 - 1534
- [2] ANALYSIS OF EFFECTOR MECHANISMS AGAINST HTLV-I-LAV-INFECTED AND HTLV-III/LAV-INFECTED LYMPHOID-CELLS [J]. JOURNAL OF IMMUNOLOGY, 1986, 136 (10): : 3619 - 3624
- [6] CHARACTERIZATION OF CELL-MEDIATED CYTOTOXICITY AGAINST HTLV-III/LAV-INFECTED CELLS [J]. CLINICAL RESEARCH, 1986, 34 (02): : A505 - A505
- [7] SERA FROM HTLV-III LAV ANTIBODY-POSITIVE INDIVIDUALS MEDIATE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY AGAINST HTLV-III LAV-INFECTED T-CELLS [J]. JOURNAL OF IMMUNOLOGY, 1987, 138 (04): : 1064 - 1067
- [8] B-CELL HYPERACTIVITY IN PATIENTS WITH HTLV-III INFECTION - EPSTEIN-BARR-VIRUS AND HTLV-III BOTH CONTRIBUTE TO THE B-CELL ACTIVATION [J]. CLINICAL RESEARCH, 1986, 34 (02): : A511 - A511
- [9] RISK OF HTLV-III LAV VIRUS IN HEMODIALYZED PATIENTS [J]. PRESSE MEDICALE, 1986, 15 (32): : 1645 - 1645